Measuring medication adherence: Are missed doses reported more accurately then perfect adherence?

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 12, Issue 4, 2000, Pages 405-408

  Wagner, G J ^a   Rabkin, J G ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; STAVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SELF REPORT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; SELF DISCLOSURE; TREATMENT REFUSAL;

EID: 0033865562     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540120050123800     Document Type: Article

References (10)

1. CHESNEY, M.A., ICKOVICS, J., HECHT, F.M., SIKIPA, G. & RABKIN, J.G. (1999). Adherence: a necessity for successful HIV combination therapy. AIDS, 13, S271-278.
2. CRAMER, J.A., MATTSON, R.H., PREVEY, M.L., SCHEYER, R.D. & OUELLETTE, V.L. (1989). How often is medication taken as prescribed? A novel assessment technique. Journal of the American Medical Association 251, 3273-3277.
3. GALLANT, J.E. & BLOCK, D.S. (1998). Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among physicians and patients. Journal of the International Association of Physicians in AIDS Care, 4, 32-35.
4. GELETKO, S.M., SEGARRA, M., RAVIN, D.S. & BABICH, M.P. (1996). Zidovudine compliance as measured by different methods in an HIV ambulatory clinic. Journal of Pharmacologic Technology, 12, 105-108.
5. HORN, T. (1998). Putting some heart into HAART. Community Prescription Service's InfoPack, 8, 2-3.
6. IMRIE, A. et al. (1997). Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Journal of Infectious Diseases, 175, 1502-1506.
7. MAYERS, D.L. (1998). Drug-resistance HIV-1: the virus strikes back. Journal of the American Medical Association, 279, 2000-2002.
8. NAKASHIMA, A.K., JONES, J.L., BURGESS, D.A. & WARD, J.W. (1998). Adherence to currently prescribed antiretroviral therapies: results from a multisite interview project. Abstract from the 12th International AIDS Conference, 28 June-3 July, Geneva, Abstract 32326.
9. PATERSON, D. et al. (1999). How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMS caps. Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, Abstract #92.
10. WATERHOUSE, D.M., CALZONE, K.A., MELE, C. & BRENNER, D.E. (1993). Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology, 11, 1189-1197.